Vericel (stock symbol: VCEL) Logo in transparent PNG and SVG formats

Vericel Logo large

Vericel Logo icon format

Vericel Logo large for dark backgrounds

Vericel Logo icon format for dark backgrounds

About Vericel

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.

  • Website domain: vcel.com
  • Employees: 281
  • Marketcap: $1.12 Billion USD

Page last updated on:

August 11th, 2022

Categories: